AKT1 and B-cell non-Hodgkin lymphoma: Together, here, we unveil the mechanism of autophagy induction by SMER28 through directly targeting the PI3K/AKT signaling axis, suggesting it as a promising lead structure for the development of anti-cancer drugs, most specifically B cell lymphomas due to its high affinity for the p110δ subunit.